CAS No. |
17086-76-9 |
|---|---|
中文名称 |
(3S,4S,5R)-4-((2R,3R)-2,3-二羟基-3-((2S,3R,5R,9R,10R,13R,17S)-2,3,14-三羟基- 10,13-二甲基-6-氧代-2,3,4,5,6,9,10,11,12,13,14,15,16,17-十四氢-1H-环戊二烯并[a]菲-17-丁基)-5-羟基-3-甲基四氢-2H-吡喃-2-酮 |
英文名称 |
(3S,4S,5R)-4-((2R,3R)-2,3-Dihydroxy-3-((2S,3R,5R,9R,10R,13R,17S)-2,3,14-trihydroxy-10,13-dimethyl-6-oxo-2,3,4,5,6,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)butyl)-5-hydroxy-3-methyltetrahydro-2H-pyran-2-one |
别名 |
5-beta-Stigmast-7-en-26-oic acid, 2-beta,3-beta,14,20,22,28-hexahydroxy-6-oxo-, gamma-lactone, (22R,24S,25S,28R)- | 5beta-Stigmast-7-en-26-oic acid, 2beta,3beta,14,20,22,28-hexahydroxy-6-oxo-, gamma-lactone, (22R,24S,25S,28R)- | HY-N0211 | CHEBI:29012 | ( |
标准英文名 |
(3S,4S,5R)-4-((2R,3R)-2,3-dihydroxy-3-((2S,3R,5R,9R,10R,13R,17S)-2,3,14-trihydroxy-10,13-dimethyl-6-oxo-2,3,4,5,6,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)butyl)-5-hydroxy-3-methyltetrahydro-2H-pyran-2-one |
MDL No. |
MFCD01683622 |
分子式 |
C29H44O9 |
分子量 |
536.66 |
精确分子量 |
536.30 |
SMILES |
O=C1[C@@H](C)[C@H](C[C@@H](O)[C@@]([C@H]2CCC3(O)C4=CC([C@]5([H])C[C@@H](O)[C@@H](O)C[C@]5(C)[C@@]4([H])CC[C@]23C)=O)(O)C)[C@@H](O)CO1 |
标准SMILES |
C[C@H]1[C@H](C[C@@H](O)[C@](C)(O)[C@H]2CCC3(O)C4=CC(=O)[C@@H]5C[C@@H](O)[C@@H](O)C[C@]5(C)[C@H]4CC[C@@]32C)[C@@H](O)COC1=O |
性状 |
Form: solid |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
BZWMGJMVOQFRLR-RXYAIQCUSA-N |
危险类别(旧) |
H302 |
存储要求 |
Keep in dark place, Inert atmosphere, 2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral,Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A),Specific target organ toxicity, single exposure; Respiratory system (Category 3) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|